Oil-based DSRP Microcrystal Suspension

Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Short-acting

Active Pharmaceutical Ingredient (API):
  • drospirenone

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Bayer HealthCare

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Active Development: No

Additional Information

References:
  • Nippe, S. (2011) Parenteral oil-based drospirenone microcrystal suspensions-Evaluation of physicochemical stability and influence of stabilising agents. Int J Pharm. 416(1): 181-8.

Vertical Tabs

Print